Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Shilpa Medicare Limited ( (IN:SHILPAMED) ).
Shilpa Medicare Limited has announced the dispatch of the notice for its 38th Annual General Meeting, as published in Business Line and Suddimoola newspapers. This announcement is part of the company’s compliance with regulatory requirements, reflecting its commitment to transparency and stakeholder engagement.
More about Shilpa Medicare Limited
Shilpa Medicare Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and formulations. The company is known for its emphasis on oncology products and has a significant presence in both domestic and international markets.
Average Trading Volume: 7,656
Technical Sentiment Signal: Buy
Current Market Cap: 82.77B INR
For an in-depth examination of SHILPAMED stock, go to TipRanks’ Overview page.